Drugs / BI 655088
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02696616 | Mar 2016 → Feb 2019 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 655088 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02696616 ↗ |
| Route | Intravenous | “Administered Intravenously” NCT02696616 ↗ |